Immupharma (IMM)

 

IMM Share PerformanceMore

52 week high70.32 17/02/17
52 week low27.12 23/05/16
52 week change 27.51 (101.87%)
4 week volume4,649,142 27/04/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Notification of Full Year Results

RNS Number: 7012F Immupharma PLC 22 May 2017 22 MAY 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") NOTIFICATION OF FULL YEAR RESULTS Date: 1 June 2017 ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, confirms that it will be announcing its full year results for the year ended 31 Decembe...

Lupuzor study on track, says ImmuPharma

ImmuPharma's phase III clinical trial of Lupuzor, its lead programme for the potential breakthrough compound for Lupu...

Update on Lupuzor Phase III Study

RNS Number: 3534F Immupharma PLC 17 May 2017 17 MAY 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Update on Lupuzor Pivotal Phase III Study ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, is pleased to provide an update of its pivotal 52-week, randomised, double-blinded, Phase III clinical trial of L...

New Employee Share Option Plan & Grant of Options

RNS Number: 1661B Immupharma PLC 31 March 2017 The following amendments have been made to the ' New Employee Share Option Plan & Grant of Options ' announcement released on 31 March 2017 at 8:33am under RNS No 1493B. The number of Ordinary Shares currently held by Dimitri Dimitriou and Robert Zimmer and their respective percentage holdin...

New Employee Share Option Plan & Grant of Options

RNS Number: 1493B Immupharma PLC 31 March 2017 31 MARCH 2017 ImmuPharma PLC New Employee Share Option Plan & Grant of Options ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that upon the recommendation of the Company's Remuneration Committee, a n...

ImmuPharma to present at Master Investor Show

RNS Number: 3981A Immupharma PLC 24 March 2017 24 MARCH 2017 IMMUPHARMA'S CHAIRMAN TO PRESENT AT MASTER INVESTOR SHOW Date: Saturday 25 March 2017, Business Design Centre, Islington ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, confirms that Tim...

Holding(s) in Company

RNS Number: 1863A Immupharma PLC 22 March 2017 22 MARCH 2017 NOTIFICATION OF MAJOR INTEREST BY ALTO INVEST ImmuPharma PLC (LSE:IMM) ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces that it has received notification by Alto Invest ("Alto") confirming its holding in ImmuPha...

Holding(s) in Company

RNS Number: 9558Z Immupharma PLC 20 March 2017 20 MARCH 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") TR1 NOTIFICATION OF MAJOR INTEREST ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, announces that it has today received a TR-1 by Aviva plc ("Aviva"). Aviva's holding in ImmuPhar...

Fundamental DataMore

EPS-4.4
Dividend yield0 %

Latest discussion posts More

  • Re: 9.5% rise...

    sliced @ 8.45am @ 58.2p
    18-Apr-2017
    Ripley94
  • Re: 9.5% rise...

    Topped up (Thursday ) ( GTC Limit 49.75p ) on since Monday at least.
    6-Apr-2017
    Ripley94
  • Re: 9.5% rise...

    This placing not mentioned on share prophets site ,daily market news ( 10.30 am ) .. they don't post all.
    10-Mar-2017
    Ripley94

Users' HoldingsMore

Users who hold Immupharma also hold..
LLOYDS GRP.30%
BP17%
NATIONAL GRID14%
RENEURON13%
SIRIUS MINERALS13%

Codes & Symbols

ISINGB0033711010
SymbolsIMM, LSE:IMM, IMM.L, IMM:LN, LON:IMM, XLON:IMM